Page 314 - AIDSBK23C
P. 314
Page 314
203 Lester RT, Yao XD, Ball TB, McKinnon LR, Kaul R, Wachihi C, Jaoko W, et al. Toll-
like receptor expression and responsiveness are increased in viraemic HIV-1 infection.
AIDS. 2008;22:685-694.
204 Ribeiro RM. Dynamics of CD4+ T cells in HIV-1 infection. Immunol Cell Biol.
2007;85:287-294.
205 Van der Kuyl AC, Cornelissen M. Identifying HIV-1 dual infections. Retrovirology.
2007;4:67.
206 Waters L, Smit E. HIV-1 superinfection. Curr Opin Infect Dis. 2012;25(1):42-50.
207 Phillips AN, Elford J, Sabin C, Bofill M, Janossy G, Lee CA. Immunodeficiency and the
risk of death in HIV infection. JAMA. 1992;268:2662-2666.
208 Kaplan JE, Benson C, Holmes KH, Brooks JT, Pau A, Masur H; Centers for Disease
Control and Prevention. Guidelines for prevention and treatment of opportunistic
infections in HIV-infected adults and adolescents: recommendations from CDC, the
National Institutes of Health, and the HIV Medicine Association of the Infectious
Diseases Society of America. MMWR Recomm Rep. 2009;58(RR-4):1-207.
209 Tsoukas CM, Bernard NF. Markers predicting progression of human immunodeficiency
virus-related disease. Clin Microbiol Rev. 1994;7:14-28.
210 Centers for Disease Control. Report of the NIH Panel to define principles of therapy of
HIV infection and guidelines for the use of antiretroviral agents in HIV-infected adults
and adolescents. MMWR. 1998;47(RR-5):1-83.
211 Roberts L, Passmore JA, Mlisana K, Williamson C, Little F, Bebell LM, Walzl G, et al.
Genital tract inflammation during early HIV-1 infection predicts higher plasma viral load
set point in women. J Infect Dis. 2012;205(2):194-203.
212 Chaisson RE, Gallant JE, Keruly JC, Moore RD. Impact of opportunistic disease on
survival in patients with HIV infection. AIDS. 1998;12:29-33.
213 Singh KK, Spector SA. Host genetic determinants of human immunodeficiency virus
infection and disease progression in children. Pediatr Res. 2009;65(5 Pt 2):55R-63R.
214 Brettle RP, Leen CLS. The natural history of HIV and AIDS in women. AIDS.
1991;5:1283-1292.
215 Chaisson RE, Keruly JC, Moore RD. Race, sex, drug use, and progression of human
immunodeficiency virus disease. N Engl J Med. 1995;333:751-756.